Novartis India Limited (BOM: 500672)
1,073.75
+4.30 (0.40%)
At close: Sep 10, 2024
Novartis India Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Cash & Equivalents | - | 449.8 | 194.2 | 1,584 | 682.7 | 791.2 | Upgrade
|
Short-Term Investments | - | 5,400 | 5,350 | 3,579 | 4,291 | 5,013 | Upgrade
|
Cash & Short-Term Investments | 5,850 | 5,850 | 5,544 | 5,163 | 4,974 | 5,804 | Upgrade
|
Cash Growth | 5.51% | 5.51% | 7.39% | 3.80% | -14.30% | -4.93% | Upgrade
|
Accounts Receivable | - | 414.7 | 361.6 | 445.6 | 387.3 | 376 | Upgrade
|
Other Receivables | - | 94.7 | 130 | 116.4 | 456.1 | 509.9 | Upgrade
|
Receivables | - | 509.4 | 491.6 | 566.6 | 844 | 886.5 | Upgrade
|
Inventory | - | 448.6 | 547.2 | 570.7 | 479.5 | 586.8 | Upgrade
|
Prepaid Expenses | - | 18.9 | 29.5 | 38.5 | 24.9 | 70.8 | Upgrade
|
Other Current Assets | - | 165.9 | 160.8 | 748.6 | 908.8 | 773.1 | Upgrade
|
Total Current Assets | - | 6,993 | 6,773 | 7,087 | 7,231 | 8,121 | Upgrade
|
Property, Plant & Equipment | - | 69.4 | 192.5 | 236.5 | 639.1 | 762.8 | Upgrade
|
Long-Term Investments | - | - | - | - | 8.3 | 8.3 | Upgrade
|
Long-Term Deferred Tax Assets | - | 153.7 | 158 | 271.8 | 302.7 | 247.4 | Upgrade
|
Other Long-Term Assets | - | 2,034 | 2,706 | 1,974 | 1,838 | 1,633 | Upgrade
|
Total Assets | - | 9,249 | 9,829 | 9,576 | 10,023 | 10,776 | Upgrade
|
Accounts Payable | - | 615.9 | 596.7 | 722 | 552 | 726 | Upgrade
|
Accrued Expenses | - | 356.7 | 343.3 | 562.6 | 203.9 | 160.9 | Upgrade
|
Short-Term Debt | - | 0.2 | - | - | - | - | Upgrade
|
Current Portion of Leases | - | 18.8 | 41.2 | 57.4 | 127 | 118.3 | Upgrade
|
Current Income Taxes Payable | - | 74.8 | 60.8 | 82.6 | 121.8 | 86.7 | Upgrade
|
Current Unearned Revenue | - | - | - | - | - | 4.6 | Upgrade
|
Other Current Liabilities | - | 505.6 | 552.9 | 739.6 | 584.8 | 1,231 | Upgrade
|
Total Current Liabilities | - | 1,572 | 1,595 | 2,164 | 1,590 | 2,328 | Upgrade
|
Long-Term Leases | - | 50.7 | 173.9 | 182.7 | 497.8 | 564.6 | Upgrade
|
Other Long-Term Liabilities | - | 31.9 | 114.7 | 56.2 | 238.1 | 223.8 | Upgrade
|
Total Liabilities | - | 1,801 | 2,073 | 2,659 | 2,911 | 3,569 | Upgrade
|
Common Stock | - | 123.4 | 123.4 | 123.4 | 123.4 | 123.4 | Upgrade
|
Retained Earnings | - | 7,288 | 7,597 | 6,779 | 6,982 | 7,080 | Upgrade
|
Comprensive Income & Other | - | 36.4 | 36 | 14.2 | 6.9 | 3.5 | Upgrade
|
Shareholders' Equity | 7,448 | 7,448 | 7,757 | 6,917 | 7,112 | 7,207 | Upgrade
|
Total Liabilities & Equity | - | 9,249 | 9,829 | 9,576 | 10,023 | 10,776 | Upgrade
|
Total Debt | 69.7 | 69.7 | 215.1 | 240.1 | 624.8 | 682.9 | Upgrade
|
Net Cash (Debt) | 5,780 | 5,780 | 5,329 | 4,923 | 4,349 | 5,121 | Upgrade
|
Net Cash Growth | 8.46% | 8.46% | 8.25% | 13.19% | -15.07% | -16.12% | Upgrade
|
Net Cash Per Share | 234.04 | 234.10 | 215.83 | 199.38 | 176.15 | 207.41 | Upgrade
|
Filing Date Shares Outstanding | 24.7 | 24.69 | 24.69 | 24.69 | 24.69 | 24.69 | Upgrade
|
Total Common Shares Outstanding | 24.7 | 24.69 | 24.69 | 24.69 | 24.69 | 24.69 | Upgrade
|
Working Capital | - | 5,421 | 5,178 | 4,923 | 5,642 | 5,793 | Upgrade
|
Book Value Per Share | 301.66 | 301.66 | 314.15 | 280.14 | 288.04 | 291.90 | Upgrade
|
Tangible Book Value | 7,448 | 7,448 | 7,757 | 6,917 | 7,112 | 7,207 | Upgrade
|
Tangible Book Value Per Share | 301.66 | 301.66 | 314.15 | 280.14 | 288.04 | 291.90 | Upgrade
|
Buildings | - | 0.5 | 0.5 | 0.9 | 1.7 | 1.7 | Upgrade
|
Machinery | - | 45.1 | 47.7 | 80.5 | 105.1 | 115 | Upgrade
|
Leasehold Improvements | - | 40.1 | 46.3 | 46.3 | 91.2 | 91.2 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.